Atezolizumab(阿替利珠单抗)
搜索文档
Exelixis(EXEL) - 2025 Q3 - Earnings Call Transcript
2025-11-05 07:02
Exelixis (NasdaqGS:EXEL) Q3 2025 Earnings Call November 04, 2025 05:00 PM ET Company ParticipantsAnastasia Parafestas - Biotech Equity Research AssociatePJ Haley - EVP of CommercialSudan Loganison - MDSusan Hubbard - EVP of Public Affairs and IRDana Aftab - EVP of Research and DevelopmentChris Senner - CFOAshwani Verma - Executive Director SMID Biotech and BiopharmaNone - Company RepresentativeMichael Morrissey - President and CEOConference Call ParticipantsAsthika Goonewardene - MD, Senior Biotech AnalystN ...